Helen Torley's Net Worth
$66.5 Million
Estimate Recalculated Apr 25, 2024 03:15PM EST
Who is Helen Torley?
Helen Torley has an estimated net worth of $66.5 Million. This is based on reported shares across multiple companies, which include QUEST DIAGNOSTICS INC, Relypsa Inc, HALOZYME THERAPEUTICS, INC., and ONYX PHARMACEUTICALS INC.
SEC CIK
Helen Torley's CIK is 0001528185
Past Insider Trading and Trends
2023 was Helen Torley's most active year for acquiring shares with 24 total transactions. Helen Torley's most active month to acquire stocks was the month of January. 2023 was Helen Torley's most active year for disposing of shares, totalling 46 transactions. Helen Torley's most active month to dispose stocks was the month of January. 2014 saw Helen Torley paying a total of $10,708,000.00 for 870,000 shares, this is the most they've acquired in one year. In 2013 Helen Torley cashed out on 182,637 shares for a total of $7,428,114.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
QUEST DIAGNOSTICS INC (DGX) Snapshot price: $127.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.83% | 1.36K |
—
|
—
| 6.26K |
May 25
| |||
Form 4
| +45.48% | 1.53K |
—
|
—
| 4.9K |
May 19
| |||
Form 4
| +104.74% | 1.72K |
—
|
—
| 3.37K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 1.64K |
—
|
—
| 1.64K |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Relypsa Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.49K |
$32.00 | -$111,584.00 |
0
|
Sep 1
| |||
Form 4
| +181.89% | 2.25K |
—
|
—
| 3.49K |
Jun 21
| |||
Form 4
| -45.02% | -1.01K |
$19.32 | -$19,569.84 | 1.24K |
Jun 7
| |||
Form 4
|
∞
| 2.25K |
—
|
—
| 2.25K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS, INC. (HALO) Snapshot price: $35.445
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +2.66% | 17.52K |
$36.10 | -$735,068.20 | 676.74K |
Feb 16
| |||
Form 4
| +3.33% | 21.22K |
$35.91 | -$885,361.05 | 659.22K |
Feb 15
| |||
Form 4
| +2.30% | 14.34K |
$35.49 | -$601,307.07 | 638K |
Feb 10
| |||
Form 4
|
—
|
0
|
$28.28 | -$864,630.00 | 623.67K |
Aug 29 - Aug 31
| |||
Form 4
|
—
|
0
|
$28.68 | -$888,720.00 | 623.67K |
Aug 15 - Aug 17
| |||
Form 4
|
—
|
0
|
$28.48 | -$876,650.00 | 623.67K |
Jul 25 - Jul 27
| |||
Form 4
|
—
|
0
|
$29.24 | -$874,750.00 | 623.67K |
Scheduled
|
Mar 7 - Mar 9
| ||
Form 4
| -1.58% | -10.00K |
—
|
—
| 623.67K |
Mar 1
| |||
Form 4
| +1.60% | 9.95K |
$49.26 | -$544,864.86 | 633.67K |
Feb 16
| |||
Form 4
| +1.00% | 6.2K |
$49.20 | -$339,086.40 | 623.72K |
Feb 15
| |||
Form 4
| +5.17% | 30.34K |
$48.92 | -$1,650,316.20 | 617.52K |
Feb 10 - Feb 12
| |||
Form 4
|
—
|
0
|
$32.84 | -$1,090,350.00 | 587.18K |
Scheduled
|
Feb 7 - Feb 9
| ||
Form 4
|
—
|
0
|
$32.98 | -$1,099,349.00 | 587.18K |
Scheduled
|
Jan 17 - Jan 19
| ||
Form 4
|
—
|
0
|
$36.39 | -$1,303,501.60 | 587.18K |
Scheduled
|
Dec 13 - Dec 15
| ||
Form 4
|
—
|
0
|
$34.03 | -$1,161,826.38 | 587.18K |
Scheduled
|
Nov 15 - Nov 17
| ||
Form 4
| +1.07% | 6.2K |
$34.43 | -$237,291.56 | 587.18K |
Feb 15 - Feb 16
| |||
Form 4
| +8.16% | 43.82K |
$34.28 | -$1,679,236.32 | 580.98K |
Feb 10 - Feb 14
| |||
Form 4
|
—
|
0
|
$27.24 | -$1,257,767.77 | 537.16K |
Scheduled
|
Nov 8
| ||
Form 4
|
—
|
0
|
$27.38 | -$1,271,389.86 | 537.16K |
Scheduled
|
Oct 4
| ||
Form 4
|
—
|
0
|
$28.52 | -$1,385,846.08 | 537.16K |
Scheduled
|
Sep 7
| ||
Form 4
|
—
|
0
|
$27.89 | -$1,322,576.04 | 537.16K |
Scheduled
|
Aug 10
| ||
Form 4
|
—
|
0
|
$30.32 | -$1,565,650.00 | 537.16K |
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
$27.16 | -$1,249,950.00 | 537.16K |
Scheduled
|
Jun 7
| ||
Form 4
|
—
|
0
|
$28.84 | -$1,418,098.66 | 537.16K |
Scheduled
|
May 11
| ||
Form 4
|
—
|
0
|
$28.60 | -$1,394,250.00 | 537.16K |
Scheduled
|
Apr 5
| ||
Form 4
|
—
|
0
|
$30.42 | -$1,576,454.44 | 537.16K |
Scheduled
|
Mar 1
| ||
Form 4
| +3.84% | 19.84K |
$48.69 | -$949,990.59 | 537.16K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +2.88% | 14.49K |
$49.84 | -$709,871.12 | 517.32K |
Feb 14
| |||
Form 4
| +6.87% | 32.31K |
$50.21 | -$1,595,103.96 | 502.83K |
Feb 10 - Feb 12
| |||
Form 4
|
—
|
0
|
$31.25 | -$1,658,917.64 | 470.52K |
Scheduled
|
Feb 1
| ||
Form 4
| -2.08% | -10.00K |
—
|
—
| 470.52K |
Nov 30
| |||
Form 4
|
—
|
0
|
$27.70 | -$1,303,567.72 | 480.52K |
Nov 25
| |||
Form 4
| -2.04% | -10.00K |
—
|
—
| 480.52K |
Aug 14
| |||
Form 4
| +4.22% | 19.84K |
$21.83 | -$425,925.13 | 490.52K |
Feb 22
| |||
Form 4
| +3.18% | 14.49K |
$21.10 | -$300,548.40 | 470.68K |
Feb 14
| |||
Form 4
| +3.76% | 16.54K |
$20.00 | -$325,180.00 | 456.19K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +8.80% | 35.58K |
$19.21 | -$382,471.10 | 439.66K |
Feb 3
| |||
Form 4
| +5.00% | 19.84K |
$16.81 | -$327,979.91 | 416.58K |
Feb 22
| |||
Form 4
| +3.79% | 14.49K |
$16.54 | -$235,595.76 | 396.74K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +4.57% | 16.7K |
$16.73 | -$243,371.31 | 382.25K |
Feb 6
| |||
Form 4
| +10.94% | 36.06K |
$16.12 | -$313,131.00 | 365.55K |
Feb 3
| |||
Form 4
| +6.41% | 19.84K |
$19.28 | -$376,172.08 | 329.49K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +5.36% | 15.76K |
$18.25 | -$282,747.25 | 309.64K |
Feb 6
| |||
Form 4
| +11.95% | 31.38K |
$18.37 | -$442,919.07 | 293.89K |
Feb 3
| |||
Form 4
| +7.52% | 18.35K |
$19.46 | -$226,689.54 | 262.51K |
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +14.68% | 31.25K |
—
|
—
| 244.16K |
Feb 6
| |||
Form 4
| +35.25% | 55.49K |
—
|
—
| 212.91K |
Feb 3
| |||
Form 4
| +23.54% | 30K |
—
|
—
| 157.42K |
Jan 6
| |||
Form 4
| +5.34% | 6.46K |
$8.63 | -$60,789.72 | 127.42K |
Jun 30
| |||
Form 4
| +19.23% | 19.51K |
$7.90 | -$92,769.70 | 120.97K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +22.03% | 18.31K |
$15.77 | -$184,288.22 | 101.46K |
Jan 6
| |||
Form 4
| +22.13% | 15.06K |
$17.33 | -$284,835.88 | 83.14K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| +36.16% | 18.08K |
$10.06 | -$119,905.14 | 68.08K |
Jan 6
| |||
Form 4
|
∞
| 50K |
$8.92 | $446,000.00 | 50K |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONYX PHARMACEUTICALS INC No price found
EVP, Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -35.91K |
$125.00 | -$4,488,875.00 |
0
|
Oct 1
| |||
Form 4
| -5.52% | -2.10K |
$123.62 | -$259,478.38 | 35.91K |
Scheduled
|
Sep 3
| ||
Form 4
| -2.23% | -1.06K |
$80.60 | -$898,477.75 | 46.59K |
Scheduled
|
Aug 12
| ||
Form 4
|
—
|
0
|
$66.22 | -$526,609.90 | 47.65K |
Scheduled
|
May 13
| ||
Form 4
| -0.97% | -466.00 |
$86.14 | -$40,141.24 | 47.65K |
Scheduled
|
Apr 1
| ||
Form 4
| +21.77% | 8.6K |
—
|
—
| 48.11K |
Mar 28
| |||
Form 4
|
—
|
0
|
$56.46 | -$365,532.50 | 39.51K |
Scheduled
|
Feb 4
| ||
Form 4
| -8.66% | -3.75K |
$54.76 | -$619,414.34 | 39.51K |
Scheduled
|
Nov 12
| ||
Form 4
| -5.08% | -2.31K |
$86.51 | -$200,184.14 | 43.26K |
Scheduled
|
Oct 4
| ||
Form 4
| -3.20% | -1.88K |
$72.78 | -$136,680.84 | 56.82K |
Scheduled
|
Sep 4
| ||
Form 4
| -3.29% | -2.00K |
$71.89 | -$143,780.00 | 58.7K |
Aug 6
| |||
Form 4
| -6.97% | -4.55K |
$73.97 | -$336,498.17 | 60.7K |
Scheduled
|
Jul 25
| ||
Form 4
| +46.63% | 20.75K |
—
|
—
| 65.25K |
Mar 30
| |||
Form 4
| +28.99% | 10K |
—
|
—
| 44.5K |
Oct 26
| |||
Form 4
|
∞
| 34.5K |
—
|
—
| 34.5K |
Aug 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||